The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...
The WHO issued new guidelines endorsing GLP-1 receptor agonists for the long-term treatment of obesity in adults. GLP-1 drugs must be combined with counseling on behavioral and lifestyle changes, the ...
Hosted on MSN
WHO releases its first guidelines on GLP-1s
The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...
Modern medicine is continually advancing treatment options for many chronic health conditions. For type 2 diabetes, obesity, and weight management, GLP-1 receptor agonists are medications that may ...
Hosted on MSN
New Guidelines on GLP-1 Drugs for Obesity Released
GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.
The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results